Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Cytospire Appoints Sumeet Ambarkhane As Chief Medical Officer
PRIVATESep 08, 2026•about 2 hours ago
Position
Chief Medical Officer
Company
Cytospire Therapeutics
Sumeet Ambarkhane, M.D.
Greater London
Description
Cytospire Therapeutics announces the appointment of Sumeet Ambarkhane, M.D., as Chief Medical Officer. Dr. Ambarkhane's extensive experience in immuno-oncology will strengthen the executive team as the company prepares for clinical studies of its lead product, CYT X300.
Company Information
Company
Cytospire Therapeutics
Location
Greater London, England, United Kingdom
About
Cytospire Therapeutics is a London-based biotech company focused on developing differentiated multispecific immune cell engager antibodies. These antibodies are designed to enhance and direct the activity of the body’s own immune system. The company aims to create first-in-class pan-gamma delta T cell engagers with the potential for safer and more efficacious cancer targeting.
Don't miss Cytospire Therapeutics's next move
Get an email the moment Cytospire Therapeutics changes its leadership, hires an exec, or expands, usually minutes after it happens.
Greater London